Welcome to our dedicated page for Modular Med news (Ticker: MODD), a resource for investors and traders seeking the latest updates and insights on Modular Med stock.
Modular Medical Inc (NASDAQ: MODD) delivers innovative insulin pump technology designed to transform diabetes care. This news hub provides investors and healthcare professionals with essential updates on the company's progress in medical device development, regulatory milestones, and strategic partnerships.
Access timely information about MODD's patented diabetes management solutions, including FDA clearances, manufacturing expansions, and clinical advancements. Our curated news collection helps stakeholders track developments in user-friendly insulin delivery systems and the company's mission to expand access to affordable diabetes technology.
Key updates include product innovation timelines, regulatory submissions, intellectual property developments, and partnership announcements. Bookmark this page for consolidated access to MODD's latest achievements in medical device engineering and diabetes care solutions.
Modular Medical, Inc. (NASDAQ:MODD) has updated its progress on the MODD-1 insulin pump, transitioning to a full commercial version designed with a tier-1 medical product manufacturer. This new version aims to resolve prior material compatibility issues, enhance cost-effectiveness, and streamline usability. The company anticipates submitting the device for FDA approval in the quarter ending December 31, 2023, following the arrival of key production equipment and subsequent testing. The initiative seeks to make insulin delivery technology more accessible and user-friendly for diabetes patients.
FAQ
What is the current stock price of Modular Med (MODD)?
What is the market cap of Modular Med (MODD)?
